Project Number 1R01AG071656-01 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) l. Growth Factors and Hormones Researcher and Organization Principal Investigator TUSZYNSKI, MARK H. Principal Investigator First Name MARK H. Principal Investigator Last Name TUSZYNSKI Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $1,201,473 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
